BNP Paribas Financial Markets’s DNA X Inc SONM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1
Closed -$3 6098
2025
Q4
$3 Hold
1
﹤0.01% 5719
2025
Q3
$13 Hold
1
﹤0.01% 5515
2025
Q2
$26 Hold
1
﹤0.01% 5383
2025
Q1
$45 Hold
1
﹤0.01% 5294
2024
Q4
$66 Hold
1
﹤0.01% 5305
2024
Q3
$61 Buy
+1
New +$63 ﹤0.01% 4083
2021
Q3
Sell
-1
Closed -$1.41K 4079
2021
Q2
$1.41K Hold
1
﹤0.01% 3918
2021
Q1
$2.06K Hold
1
﹤0.01% 3896
2020
Q4
$1.82K Sell
1
-3
-75% -$3.28K ﹤0.01% 4002
2020
Q3
$5.32K Sell
4
-32
-89% -$51.4K ﹤0.01% 4009
2020
Q2
$51.3K Buy
36
+34
+1,700% +$54.3K ﹤0.01% 3020
2020
Q1
$2.19K Buy
2
+1
+100% +$4.79K ﹤0.01% 4117
2019
Q4
$5.61K Buy
+1
New +$4.93K ﹤0.01% 4180
2019
Q3
Hold
0
4419
2019
Q2
Hold
0
4479

Other funds holding SONM

BNP Paribas Financial Markets's SONM Position: Q1 2026 in Review

BNP Paribas Financial Markets sold out of DNA X Inc (SONM) in Q1 2026, closing a stake of 1 share — an estimated $3 sold.

BNP Paribas Financial Markets first reported a position in SONM in Q4 2019 and held it in 13 quarters. The position peaked at $51.3K in Q2 2020. 9 funds tracked by Wall St. Rank hold SONM as of Q1 2026.

  • BNP Paribas Financial Markets reported no remaining DNA X Inc position as of Q1 2026 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 1 DNA X Inc share in Q1 2026, an estimated $3.
  • BNP Paribas Financial Markets first reported a position in DNA X Inc in Q4 2019 and held it in 13 quarters.
  • BNP Paribas Financial Markets's DNA X Inc position peaked at $51.3K in Q2 2020.
  • 9 funds tracked by Wall St. Rank held DNA X Inc as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.